
June 24 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI:
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA IN EUROPE
RECORDATI TO PAY AMARIN AN UPFRONT CASH PAYMENT OF US$ 25 MILLION
AMARIN TO SUPPLY FINISHED PRODUCT TO RECORDATI, IS ELIGIBLE TO RECEIVE ROYALTIES FOR SUPPLY OF PRODUCT UNDER TERMS OF AGREEMENT, COMMERCIAL MILESTONES UP TO TOTAL OF US$ 150 MILLION IF ANNUAL REVENUES FOR VAZKEPA® IN TERRITORIES IN SCOPE EXCEED CERTAIN SALES THRESHOLDS STARTING FROM € 100 MILLION
MORE DETAILS TO BE PROVIDED ON JULY 30